Monica M. K.
- Country
- Norway
- Department
- Pediatric
Research Overview
- Evaluation of Rituximab and Chemotherapy Regimens in Pediatric Aggressive B-cell Lymphoma and Leukemia: A Randomized Controlled Trial
- Evaluation of Dexamethasone Versus Prednisone in Induction Therapy for Pediatric and Adolescent Lymphoblastic Lymphoma: A Randomized Controlled Trial
- Evaluation of Cladribine-Based Regimen in Pediatric and Adolescent Langerhans Cell Histiocytosis: A Randomized, Multicenter Clinical Trial
Data & Insights
Has run more than one trial at 101 of 198 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating acute myeloid leukemia (AML) and various types of lymphomas in pediatric and adolescent populations.
- B-cell lymphomas and leukemias
- Lymphoblastic lymphoma
- Pediatric AML management
Their work focuses on developing innovative therapeutic approaches for blood cancers in young patients.
Rare Diseases
The investigator has expertise in treating Langerhans Cell Histiocytosis (LCH), a rare disorder affecting multiple body systems in children and adolescents.
- Multi-system LCH
- Single-system LCH
- CNS-Risk lesions
Their research addresses both localized and systemic manifestations of histiocytic disorders.
Pediatric Oncology
The investigator concentrates on developing therapeutic protocols specifically designed for children and adolescents with various forms of cancer.
- Risk-adapted treatment strategies
- Early intervention protocols
- Long-term outcome optimization
Their work emphasizes age-appropriate treatment approaches in pediatric cancer care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.